×
  • Catégorie
  • Type
  • Advanced

National Immunization Strategy (NIS) - Introduction and overview

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 11: COVID-19 Vaccination financing in the South-East Asia Region

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 13: Mini-cPIE lessons learned highlights and regional perspectives

Global Market Study : Malaria - 2021

Group B Streptococcus vaccine: full value of vaccine assessment. Financial analysis

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 12: Operational Microplanning for COVID-19 Vaccination and experience with multiple products

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 10: Gavi and UNICEF’s Covid-19 Delivery Support: Everything you Need to Know About Needs-Based Applications

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 09: Experience sharing by Western Pacific and Eastern Mediterranean countries: COVID-19 vaccination costing, public financial management and economic return

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 04: Costing Alone is Not Enough: Budgets Need to be Planned and Executed

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 07: Regional approach to support COVID-19 vaccination costing and budgeting in countries in the Americas and Europe

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 08: Pfizer-BioNTech COVID-19 Vaccine: Planning and Implementation

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 06: Process of COVID-19 Vaccination Planning, Costing and Budgeting in African Region

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session 05: Where does needed COVID-19 Vaccination Funding come from?

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Sessions #02 and #03: COVID-19 Vaccination: Costing for Scale-up

Costing, Budgeting, Financing and Delivery of COVID-19 Vaccines - Q&A for Session #01: How to apply for Gavi CDS Funding through the Partners Platform

Are rotavirus vaccines a good investment for middle-income countries?

Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 22 July 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness

Q&A for Session #13: Private Sector Engagement

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study

COVID-19 Vaccine Introduction and deployment Costing tool (‎‎‎‎CVIC tool)